OpiCalc Logo

OpiCalc

--- Clinical Tools

Logo
OpiCalc
APGAR ScoreAssisted Delivery (FIGO)BPP (Manning Score)Bishop ScoreCARPREG II Cardiac RiskCervical Cancer StagingContraceptive Pearl IndexDoppler Matrix (UA/MCA)EFW (Hadlock)Endometrial StagingEndometrial ThicknessFGR Criteria (Consensus)FSFI (Sexual Function)Ferriman-Gallwey ScoreFetal Anemia (MCA PSV)GDM Diagnostic CriteriaGPA History IndicatorGail Model Breast RiskGestational Dating (LMP)HIV PMTCT ProtocolIOTA Simple RulesIVF Due Date & AMHIron Deficit (Ganzoni)Labour Progress (WHO)Maternal Sepsis (qSOFA)O-RADS ClassificationOvarian Cancer StagingPAS Hemorrhage RiskPPH Protocol (FIGO)Preeclampsia (ACOG)Rho(D) Dose (K-B)Rotterdam PCOS CriteriaSyphilis ManagementTORCH FrameworkVBAC Success ProbabilityVulvar Cancer StagingWeight Gain (IOM)mWHO Cardiac Risk

Preeclampsia (ACOG)

Diagnostic Thresholds

Severe Features (ACOG)

NORMAL RANGE

Obstetric Classification Framework

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

When to Use

  • Evaluation of pregnant patients ≥20 weeks gestation with new-onset hypertension.
  • Assessment of postpartum patients (up to 6 weeks) presenting with hypertension or headache.
  • Differentiating gestational hypertension from preeclampsia.
  • Identifying preeclampsia with severe features requiring immediate hospitalization.

Blood Pressure Thresholds

Diagnosis requires Systolic BP ≥140 mmHg or Diastolic BP ≥90 mmHg on two occasions at least 4 hours apart. Severe range BP (≥160/110) can be confirmed within minutes to facilitate rapid antihypertensive therapy.

CLINICAL INSIGHT

How it Works

Diagnostic Criteria

  • New-onset HTN (≥140/90) AFTER 20 weeks gestation PLUS:
  • Proteinuria (≥300 mg/24h, P:C ratio ≥0.3, or 2+ dipstick)
  • OR (in the absence of proteinuria) new-onset systemic dysfunction:
  • Platelets < 100,000/μL
  • Serum creatinine > 1.1 mg/dL (or doubling in absence of renal disease)
  • Liver transaminases 2x upper limit of normal
  • Pulmonary edema
  • New-onset cerebral or visual disturbances

Defining "Severe Features"

Blood Pressure
Thrombocytopenia
Liver Function
Renal Insufficiency
Pulmonary
Neurological
CLINICAL INSIGHT

Practical Pearls

Critical Pearls

  • Proteinuria is NO LONGER required for diagnosis if other systemic features are present.
  • "Mild" preeclampsia is an obsolete term; the condition is now categorized as "Preeclampsia without Severe Features" or "Preeclampsia with Severe Features."
  • Postpartum preeclampsia: Up to 30% of eclamptic seizures occur postpartum, often in patients who were normotensive at discharge.
  • Epigastric pain is often misdiagnosed as GERD; in a hypertensive gravid patient, it is a marker of hepatic capsular stretch and a severe feature.

Risk Factors for Prophylaxis

High-risk patients (Prior preeclampsia, multifetal gestation, CKD, autoimmune disease, T1DM/T2DM, chronic HTN) should be started on low-dose Aspirin (81–162 mg/day) between 12 and 28 weeks gestation.

CLINICAL INSIGHT

Next Steps

Management: Without Severe Features

  • Serial labs (CBC, LFTs, Cr) and BP monitoring 1–2x weekly.
  • Fetal surveillance (NST/BPP) and serial growth scans.
  • Delivery indicated at 37 0/7 weeks gestation.

Management: With Severe Features

  • Hospitalization for the duration of pregnancy.
  • Magnesium Sulfate for seizure prophylaxis.
  • Antihypertensives (Labetalol, Hydralazine, or Nifedipine) for SBP ≥160 or DBP ≥110.
  • Delivery indicated at 34 0/7 weeks (or earlier if maternal/fetal condition destabilizes).
  • Administer corticosteroids for fetal lung maturity if <34 weeks.

Differential Diagnosis

CLINICAL INSIGHT

Evidence Base

Current Gold Standard

Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222.

ACOG (American College of Obstetricians and Gynecologists)Obstet Gynecol.2020

Seizure Prophylaxis Evidence

Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial.

Altman D, Carroli G, Duley L, et al.Lancet.2002
CLINICAL INSIGHT

Background

Evolution of the Diagnosis

Historically known as "toxemia," preeclampsia was long thought to be caused by a circulating toxin. We now recognize it as a complex multisystem syndrome driven by placental malperfusion and systemic endothelial dysfunction.

The Move Away from Proteinuria

In 2013, the ACOG Task Force on Hypertension in Pregnancy fundamentally changed the diagnostic landscape by removing the absolute requirement for proteinuria, recognizing that women can progress to eclamptic seizures or HELLP syndrome without significant renal protein excretion.